Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Type I C1 inhibitor deficiency with a small messenger RNA resulting from deletion of one exon.
T Ariga, … , M Cicardi, A E Davis 3rd
T Ariga, … , M Cicardi, A E Davis 3rd
Published June 1, 1989
Citation Information: J Clin Invest. 1989;83(6):1888-1893. https://doi.org/10.1172/JCI114095.
View: Text | PDF
Research Article Article has an altmetric score of 3

Type I C1 inhibitor deficiency with a small messenger RNA resulting from deletion of one exon.

  • Text
  • PDF
Abstract

The molecular genetic basis of C1 inhibitor (C1 INH) deficiency in a patient with type I hereditary angioneurotic edema was studied. This patient was found to have an abnormally short C1 INH mRNA together with a normal message. Restriction fragment length polymorphism of the C1 INH gene was detected by Southern blot analysis of the patient's DNA after digestion with Pst I or Sac I, and hybridization with a full-length C1 INH cDNA. Hybridization of the same blot with three different fragments of the full-length cDNA suggested that exon VII and portions of both flanking introns were deleted in the C1 INH gene. Northern blot analysis of RNA from cultured monocytes, using a probe corresponding to exon VII, also indicated that the abnormal C1 INH mRNA had a deletion of these nucleotides. To confirm the hypothesis that the short C1 INH mRNA contained a deletion, the involved segment of the patient's C1 INH mRNA was amplified using the polymerase chain reaction (PCR). PCR amplification yielded two C1 INH DNA fragments of different lengths (380 and 160 bp). Southern blot and sequence analysis of both DNA fragments clearly revealed that the smaller 160-bp DNA was derived from the abnormal message and had a deletion of nucleotides corresponding to exon VII.

Authors

T Ariga, T Igarashi, N Ramesh, R Parad, M Cicardi, A E Davis 3rd

×

Total citations by year

Year: 2021 2020 2019 2017 2014 2012 2011 2005 2004 2003 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 Total
Citations: 1 1 1 1 1 12 1 1 1 1 2 1 1 1 1 1 1 1 5 3 7 3 48
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (48)

Title and authors Publication Year
Evidence for a dominant‐negative effect of a missense mutation in the SERPING1 gene responsible for hereditary angioedema type I
S Yasuno, O Ansai, R Hayashi, S Nakamura, Y Shimomura
The Journal of Dermatology 2021
A novel deep intronic SERPING1 variant as a cause of hereditary angioedema due to C1-inhibitor deficiency
S Vatsiou, M Zamanakou, G Loules, F Psarros, F Parsopoulou, D Csuka, A Valerieva, M Staevska, G Porebski, K Obtulowicz, M Magerl, M Maurer, M Speletas, H Farkas, AE Germenis
Allergology international : official journal of the Japanese Society of Allergology 2020
International Consensus on the Use of Genetics in the Management of Hereditary Angioedema
AE Germenis, M Margaglione, JB Pesquero, H Farkas, S Cichon, D Csuka, AL Lera, M Rijavec, S Jolles, A Szilagyi, ML Trascasa, CL Veronez, C Drouet, M Zamanakou, S Andrejevic, E Aygören-Pürsün, NA Bara, J Bernstein, K Bork, L Bouillet, M Bova, HH Boysen, A Bygum, T Caballero, A Castaldo, S Christiansen, M Cicardi, J Fabiani, C Katelaris, G Dewald, NM Gökmen, MT Gonzalez-Quevedo, J Gooi, V Grivcheva-Panovska, A Grumach, R Hakl, G Hardy, M Jesenak, A Kaplan, M Kirschfink, KV Köhalmi, I Leibovich, HJ Longhurst, W Lumry, M Magerl, IM Saguer, IB Nagy, S Nieto, P Nordenfelt, G Porębski, F Psarros, A Reshef, MA Riedl, F Sheikh, S Peter, M Speletas, M Staevska, M Stobiecki, M Triggiani, N Veszeli, S Waserman, C Weber, W Wuillemin, B Zuraw
The Journal of Allergy and Clinical Immunology: In Practice 2019
NEIL1 is a candidate gene associated with common variable immunodeficiency in a patient with a chromosome 15q24 deletion
R Romano, A Zaravinos, K Liadaki, R Caridha, J Lundin, G Carlsson, J Winiarski, Q Pan-Hammarström, L Hammarström
Clinical Immunology 2017
Autoimmunity by haploinsufficiency
F Rieux-Laucat, JL Casanova
Science 2014
Molecular Dermatology
C Has, C Sitaru
2012
Molecular Dermatology
C Has, C Sitaru
2012
Molecular Dermatology
C Has, C Sitaru
2012
Molecular Dermatology
C Has, C Sitaru
2012
Molecular Dermatology
C Has, C Sitaru
2012
Molecular Dermatology
C Has, C Sitaru
2012
Molecular Dermatology
C Has, C Sitaru
2012
Molecular Dermatology
C Has, C Sitaru
2012
Molecular Dermatology
C Has, C Sitaru
2012
Molecular Dermatology
C Has, C Sitaru
2012
Molecular Dermatology
C Has, C Sitaru
2012
Molecular Dermatology
C Has, C Sitaru
2012
SERPING1 mutations in 59 families with hereditary angioedema
A López-Lera, S Garrido, O Roche, M López-Trascasa
Molecular Immunology 2011
Hereditary angioedema: The mutation spectrum ofSERPING1/C1NHin a large Spanish cohort
O Roche, A Blanch, C Duponchel, G Fontán, M Tosi, M López-Trascasa
Human Mutation 2005
Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond
A Agostoni, E Aygorenpursun, K Binkley, A Blanch, K Bork, L Bouillet, C Bucher, A Castaldo, M Cicardi, A DAVISIII
Journal of Allergy and Clinical Immunology 2004
Angio-œdèmes héréditaires par déficit en C1 inhibiteur : la gravité du pronostic n’est pas liée à l’anomalie du gène
MT Guinnepain, V Fremeaux-Bacchi, J Blouin, J Laurent
Revue Française d'Allergologie et d'Immunologie Clinique 2003
A Review of the Reported Defects in the Human C1 Esterase Inhibitor Gene Producing Hereditary Angioedema Including Four New Mutations
B Bowen, JJ Hawk, S Sibunka, S Hovick, JM Weiler
Clinical Immunology 2001
Expression of C1 Esterase Inhibitor by the Baculovirus Expression Vector System: Preparation, Purification, and Characterization
MW Wolff, F Zhang, JJ Roberg, EE Caldwell, PR Kaul, JN Serrahn, DW Murhammer, RJ Linhardt, JM Weiler
Protein Expression and Purification 2001
Detection of C1 inhibitor mutations in patients with hereditary angioedema
BL Zuraw, J Herschbach
Journal of Allergy and Clinical Immunology 2000
Angioedema associated with C1 inhibitor deficiency
J Laurent, MT Guinnepain
Clinical Reviews in Allergy & Immunology 1999
The Human Complement System in Health and Disease
J Ahearn, A Rosengard
The Human Complement System in Health and Disease 1998
Les angio-œdèmes par déficit en C1 inhibiteur
J Laurent, MT Guinnepain
Revue Française d'Allergologie et d'Immunologie Clinique 1997
Review
M Epstein
Renal Failure 1996
A mutation unique in serine protease inhibitors (serpins) identified in a family with type II hereditary angioneurotic edema
JG Ocejo-Vinyals, F Leyva-Cobián, JL Fernández-Luna
Molecular Medicine 1995
Molecular genetic studies of two families with X-linked chronic granulomatous disease: Mutation analysis and definitive determination of carrier status in patients' sisters
T Ariga, Y Sakiyama, H Furuta, S Matsumoto
European Journal of Haematology 1994
Transinhibition of C1 inhibitor synthesis in type I hereditary angioneurotic edema
J Kramer, FS Rosen, HR Colten, K Rajczy, RC Strunk
Journal of Clinical Investigation 1993
C1-Inhibitor and Its Genetic Alterations in Hereditary Angioneurotic Edema
VH Donaldson
International Reviews of Immunology 1993
A newly recognized point mutation in the cytochrome b558 heavy chain gene replacing alanine57 by glutamic acid, in a patient with cytochrome b positive X-linked chronic granulomatous disease
T Ariga, Y Sakiyama, K Tomizawa, S Imajoh-Ohmi, S Kanegasaki, S Matsumoto
European Journal of Pediatrics 1993
The Polymerase Chain Reaction: Applications in Dermatology
JL Snow, K Snow, MR Pittelkow
The Journal of Dermatologic Surgery and Oncology 1993
Complement in Health and Disease
K Whaley, M Loos, JM Weiler
1993
Peripheral edema due to increased vascular permeability: a clinical appraisal
A Agostoni, M Cicardi, W Porreca
International Journal of Clinical & Laboratory Research 1992
The polymerase chain reaction and other amplification techniques in immunological research and diagnosis
AM Lew, RB Brandon, M Panaccio, CJ Morrow
Immunology 1992
Urticaria and angioedema
DP Huston, RB Bressler
Medical Clinics of North America 1992
Synthesis of C1 inhibitor in fibroblasts from patients with type I and type II hereditary angioneurotic edema
J Kramer, Y Katz, FS Rosen, AE 3rd, RC Strunk
Journal of Clinical Investigation 1991
Restriction fragment length polymorphism analysis of the C1-inhibitor gene in hereditary C1-inhibitor deficiency
AR McPhaden, GD Birnie, K Whaley
Clinical Genetics 1991
Complete nucleotide sequence of the gene for human C1 inhibitor with an unusually high density of Alu elements
PE CARTER, C DUPONCHEL, M TOSI, JE FOTHERGILL
European Journal of Biochemistry 1991
The Urticarias 1990
AK Black, M Greaves, R Champion, R Pye
British Journal of Dermatology 1991
Gene Amplification by Polymerase Chain Reaction in Dermatology
D Schadendorf, BM Czarnetzki
Journal of Investigative Dermatology 1991
Long-term treatment of hereditary angioedema with attenuated androgens: A survey of a 13-year experience
M Cicardi, L Bergamaschini, M Cugno, E Hack, G Agostoni, A Agostoni
Journal of Allergy and Clinical Immunology 1991
Genetic defects of the complement system
FS Rosen
Clinical Immunology and Immunopathology 1991
The polymerase chain reaction: Miracle or mirage? A critical review of its uses and limitations in diagnosis and research
PA Wright, D Wynford-Thomas
The Journal of Pathology 1990
Recombinations between Alu repeat sequences that result in partial deletions within the C1 inhibitor gene
T Ariga, PE Carter, AE Davis
Genomics 1990
Application of the polymerase chain reaction to the diagnosis of human genetic disease
J Reiss, DN Cooper
Human Genetics 1990

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 Wikipedia pages
17 readers on Mendeley
See more details